At Orbis, we're incredibly lucky to work with some amazing individuals, companies, government departments and embassies across the Middle East and beyond. Here you can learn more about their support and discover how you too could help us tackle avoidable blindness worldwide.
Training is at the very heart of everything we do. With the help of our world-leading expert medical volunteers, we provide training to all types of healthcare workers – from doctors and nurses in regional hospitals to district leaders and teachers in remote areas.
At Orbis, we're incredibly lucky to work with some amazing individuals, companies, government departments and embassies across the Middle East and beyond. Here you can learn more about their support and discover how you too could help us tackle avoidable blindness worldwide.
415,000+ Antibiotics Distributed Through QFFD Funded Programme
Thanks to support from Qatar Fund for Development, we're working with partners in Ethiopia to tackle blinding Trachoma. Part of the Qatar Creating Vision initiative, the project this year has distributed 415,000+ doses of antibiotics across Amaro, Burji and Gedeo, to work towards the elimination of the disease.
A colossal 55% of the world’s burden of Trachoma can be found in Ethiopia, with 64 million of the population at risk of developing the painful condition and 70% of cases in the country impacting women and girls.
Trachoma is a is highly contagious disease yet is easily preventable and treatable through the World Health organisation’s SAFE strategy:
Surgery,
Antibiotics,
Facial Cleanliness,
Environmental improvements.
In rural Ethiopia, the burden of the disease remains high, as medical support can be hard to reach. Through repeated infection from childhood, Trachoma Trichiasis can develop, causing a person's eye lashes to turn inwards, scraping across the eye's surface with every excruciating blink. Unless they have access to treatment, such as surgery, multiple infections can result in permanent blindness.
To support the distribution of the antibiotics, almost 900 government officials, health workers and volunteers were trained by Orbis to deliver the drug by going door to door, ensuring those in remote areas were reached, helping to protect communities against the infection.
HE Mr. Khalifa bin Jassim Al-Kuwari, Director General of Qatar Fund for Development, stated: "We proudly support Qatar Creating Vision in partnership with Orbis to combat Trachoma in Ethiopia. The distribution of 415,000 antibiotics marks a significant stride in eliminating this eye disease. Our collaboration underscores our commitment to global health challenges, aiming to contribute to the WHO's goal of eliminating Trachoma by 2030, ensuring a healthier future for at-risk communities."
Rebecca Cronin, CEO of Orbis UK said: “Mass Dug Administrations are a powerful tool in the fight against Trachoma. The World Health Organisation has set a goal of eliminating the condition as a public health issue by 2030. Trachoma can be found in areas with limited sanitation and clean water. It has blighted communities for thousands of years and has no place in our modern world. It is thanks to supporters, such as the Qatar Fund for Development, that we’re able to work with partners towards achieving the target, bringing vital eye care to communities across Ethiopia.”
Between 2016 and 2020 in India and Bangladesh, thanks to the generosity of the Qatar Fund for Development, Orbis and our strategic partners provided more than 6 million eye tests and treatments, mainly to children, through Qatar Creating Vision. The project in Ethiopia launched phase two of the initiative in April 2022, and earlier this year, a project in Zambia began, to tackle paediatric blindness.
You’ve landed on Orbis [country name from subdomain].
There may be more relevant content for you on Orbis [country name your IP maps to].
Disclaimer
Please know that you are now leaving the Orbis.org domain and
will be redirected to a third-party site.
You should know that Project Orbis International, Inc. (“Orbis”)
makes no representation, warranty, or guarantee regarding the reliability,
quality, security, suitability, or availability of the services requested
through the use of our third-party referral sites, and that your use of
this referral service is at your own risk. Orbis is not liable for any
harm resulting from the conduct of any third-party service provider or
other user of the referral service, including illegal conduct. Third-party
websites are subject to their own terms and policies, including privacy and
data gathering practices. In addition, Orbis is not responsible for the use
of any personal information you disclose on third-party sites, including use
by unauthorized users. Thank you for your understanding.